FLUOROPHARMA MEDICAL, INC.

No description available

5.01,5.02,9.01

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

No description available

1.01,2.03,3.02,9.01

1.01,3.03,5.02,9.01

2.03,5.02,9.01

General form for quarterly reports under Section 13 or 15(d) (amendment)

1.01,3.02,9.01

General form for quarterly reports under Section 13 or 15(d)

Entry into a Material Definitive Agreement

2.03

1.01,5.03,5.07,9.01

General form for quarterly reports under Section 13 or 15(d)

1.01,9.01

No description available

Definitive Proxy Statement

7.01,9.01

Preliminary Proxy Statement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Entry into a Material Definitive Agreement

06b

Annual report pursuant to Section 13 or 15(d)

1.01,2.03,3.02,9.01

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Correspondence with the SEC

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

1.01,9.01

5.02

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Post-effective amendment to a registration statement

5.02,9.01

Letter from the SEC

1.01

Registration (IPO) statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Post-effective amendment to a registration statement

General form for quarterly reports under Section 13 or 15(d)

06b

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

No description available

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

No description available

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

Spoor Johan M.

CHALMERS ANNA